Pathologic findings | Groups | |||
---|---|---|---|---|
C | CLP-SAL | CLP-AD-MSC | CLP-AD-MSC-EPA | |
Liver | ||||
Hepatocyte disarrangement | 1 (0.5–1) | 9 (8.5–10.5)* | 8 (7–8.5)* | 2 (2–3)*,#,‡ |
Kupffer cell hyperplasia | 1 (1–1) | 9 (9–9)* | 6 (6–6)*,# | 4 (3–4)*,#,‡ |
Hydropic degeneration | 1 (1–1) | 6 (5–7.5)* | 3 (3–4.5)*,# | 2 (2–3)*,# |
Kidney | ||||
Tubular acute necrosis | 0 (0–0.5) | 12 (10.5–12)* | 6 (5–6)*,# | 2 (2–3)*,#,‡ |
Heart | ||||
Disarrangement of cardiac myocyte architecture | 1 (0.5–1) | 6 (5–6)* | 4 (3–4)*,# | 2 (2–3)*,#,‡ |
Interstitial edema | 1 (0.5–1) | 6 (6–7.5)* | 2 (2–2)*,# | 2 (1.5–2)*,# |
Microvacuolization | 1 (1–1) | 9 (7.5–9)* | 2 (1.5–2)*,# | 2 (1.5–2)*,# |
Spleen | ||||
Increased number of megakaryocytes | 1 (0.5–1) | 12 (10.5–12)* | 6 (5–6)*,# | 2 (2–3)*,#,‡ |
Increased number of lymphocytes | 1 (1–1.5) | 8 (7–8)* | 6 (5–6)*,# | 2 (2–2)*,#,‡ |
Small bowel | ||||
Villi architecture disorganization | 1 (0.5–1) | 12 (10–12)* | 6 (5–6)*,# | 2 (2–3)*,#,‡ |
Edema of lamina propria | 0 (0–0.5) | 9 (8.5–9)* | 4 (4–5)*,# | 4 (3–4)*,# |
Number of enteroblasts (crypt cells) | 0 (0–0.5) | 6 (6–7)* | 4 (4–5)*,# | 4 (3–4)*,# |